-
Views
-
Cite
Cite
G. Bachmann, Pain: Patients Supplement Clinician Prescribed Management, The Journal of Sexual Medicine, Volume 16, Issue 8, August 2019, Pages 1128–1129, https://doi.org/10.1016/j.jsxm.2019.05.020
Close - Share Icon Share
Extract
The common theme repeated throughout human history, just as this article, “Vulvodynia, ‘A Really Great Torturer’: A Mixed Methods Pilot Study Examining Pain Experiences and Drug/Non-Drug Pain Relief Strategies” by Schlaeger et al notes, is that pain, including vulvodynia pain, continues to be a problem for humans, despite a wide spectrum of attempted strategies—with the potential for overdose—to ameliorate it.1 Pain has been an elusive, adverse experience in humans since early times, with numerous physicians, philosophers, and scientists commenting on its cause and management for generations. Clearly, even with the thousands of years of research and discovery that humans have invested in the pursuit of physical pain elimination, there still is not a non-addictive pain management strategy that is universally effective with minimal risk for all persons who report a particular pain type. Even today with advanced technology and multiple pharmacologic therapies available to clinicians, pain control for most individuals continues to elude objective quantifying and effective management by the use of safe interventions that are not habit-forming. And, regardless of clinician-prescribed management, or “self-treatment” interventions determined by individuals with pain, such as those used by women with vulvodynia as reported by Schlaeger et al, individuals suffering from chronic pain continue to report inadequate pain relief and may look to a combination of interventions that are often cumulative central nervous system depressants.1
